Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Thittaya Audomsun"'
Autor:
Thanarath Imsuwansri, Thitinan Jongthitinon, Niramon Pojdoung, Nuntana Meesiripan, Siriwan Sakarin, Chatikorn Boonkrai, Tossapon Wongtangprasert, Tanapati Phakham, Thittaya Audomsun, Chadaporn Attakitbancha, Pijitra Saelao, Phijitra Muanwien, Maoxin Tim Tian, Songsak Tongchusak, Bhrus Sangruji, Dhammika Leshan Wannigama, Chenphop Sawangmake, Watchareewan Rodprasert, Quynh Dang Le, Steven Dwi Purbantoro, Kananuch Vasuntrarak, Sirirat Nantavisai, Supakit Sirilak, Ballang Uppapong, Sompong Sapsutthipas, Sakalin Trisiriwanich, Thitiporn Somporn, Asmah Usoo, Natthakarn Mingngamsup, Supaporn Phumiamorn, Porawan Aumklad, Kwanputtha Arunprasert, Prasopchai Patrojanasophon, Praneet Opanasopit, Norapath Pesirikan, Ladda Nitisaporn, Jesada Pitchayakorn, Thana Narkthong, Bancha Mahong, Kumchol Chaiyo, Kanjana Srisutthisamphan, Ratchanont Viriyakitkosol, Songklot Aeumjaturapat, Anan Jongkaewwattana, Sakarn Bunnag, Trairak Pisitkun
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract An HPMC-based nasal spray solution containing human IgG1 antibodies against SARS-CoV-2 (nasal antibody spray or NAS) was developed to strengthen COVID-19 management. NAS exhibited potent broadly neutralizing activities against SARS-CoV-2 wit
Externí odkaz:
https://doaj.org/article/0629312cc945435bb6f6a4a61ad5c035
Autor:
Tanapati Phakham, Chatikorn Boonkrai, Tossapon Wongtangprasert, Thittaya Audomsun, Chadaporn Attakitbancha, Pijitra Saelao, Phijitra Muanwien, Sarintip Sooksai, Nattiya Hirankarn, Trairak Pisitkun
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Abstract Programmed cell death protein 1 (PD-1) plays a significant role in suppressing antitumor immune responses. Cancer treatment with immune checkpoint inhibitors (ICIs) targeting PD-1 has been approved to treat numerous cancers and is the backbo
Externí odkaz:
https://doaj.org/article/fe975aa66faf45768d418c41cc1d6b44
Efficacy of the combination of monoclonal antibodies against the SARS-CoV-2 Beta and Delta variants.
Autor:
Chatikorn Boonkrai, Thomas S Cotrone, Watchadaporn Chaisuriyong, Terapong Tantawichien, Usa Thisyakorn, Stefan Fernandez, Taweewun Hunsawong, Matthew Reed, Tossapon Wongtangprasert, Thittaya Audomsun, Tanapati Phakham, Chadaporn Attakitbancha, Pijitra Saelao, Dorota Focht, Raymond Kimbung, Martin Welin, Aijaz Ahmad Malik, Trairak Pisitkun, Nattachai Srisawat
Publikováno v:
PLoS ONE, Vol 18, Iss 5, p e0284173 (2023)
The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently the biggest healthcare issue worldwide. This study aimed to develop a monoclonal antibody against SARS-CoV-2 from B cells of recovered COVID-19 patients, which
Externí odkaz:
https://doaj.org/article/f90cda5ef3fd48818ea0a99039882428
Autor:
Thanarath Imsuwansri, Thitinan Jongthitinon, Niramon Pojdoung, Nuntana Meesiripan, Siriwan Sakarin, Chatikorn Boonkrai, Tossapon Wongtangprasert, Tanapati Phakham, Thittaya Audomsun, Chadaporn Attakitbancha, Pijitra Saelao, Phijitra Muanwien, Maoxin Tim Tian, Songsak Tongchusak, Bhrus Sangruji, Dhammika Leshan Wannigama, Chenphop Sawangmake, Watchareewan Rodprasert, Quynh Dang Le, Steven Dwi Purbantoro, Kananuch Vasuntrarak, Sirirat Nantavisai, Supakit Sirilak, Ballang Uppapong, Sompong Sapsutthipas, Sakalin Trisiriwanich, Thitiporn Somporn, Asmah Usoo, Natthakarn Mingngamsup, Supaporn Phumiamorn, Porawan Aumklad, Kwanputtha Arunprasert, Prasopchai Patrojanasophon, Praneet Opanasopit, Norapath Pesirikan, Ladda Nitisaporn, Jesada Pitchayakorn, Thana Narkthong, Bancha Mahong, Kumchol Chaiyo, Kanjana Srisuthisamphan, Ratchanont Viriyakitkosol, Songklot Aeumjaturapat, Anan Jongkaewwattana, Sakarn Bunnag, Trairak Pisitkun
Successful COVID-19 prevention requires additional measures beyond vaccination, social distancing, and masking. A nasal spray solution containing human IgG1 antibodies against SARS-CoV-2 (COVITRAP™) was developed to strengthen other COVID-19 preven
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8080ab7b66efaf78699de5510765094a
https://doi.org/10.1101/2022.10.04.22280574
https://doi.org/10.1101/2022.10.04.22280574
Autor:
Imsuwansri, Thanarath1 (AUTHOR) drthanarath@gmail.com, Jongthitinon, Thitinan1 (AUTHOR), Pojdoung, Niramon1 (AUTHOR), Meesiripan, Nuntana1 (AUTHOR), Sakarin, Siriwan1 (AUTHOR), Boonkrai, Chatikorn2 (AUTHOR), Wongtangprasert, Tossapon2,3 (AUTHOR), Phakham, Tanapati2 (AUTHOR), Audomsun, Thittaya2 (AUTHOR), Attakitbancha, Chadaporn2 (AUTHOR), Saelao, Pijitra2 (AUTHOR), Muanwien, Phijitra2 (AUTHOR), Tian, Maoxin Tim2 (AUTHOR), Tongchusak, Songsak2 (AUTHOR), Sangruji, Bhrus4 (AUTHOR), Wannigama, Dhammika Leshan5,6 (AUTHOR), Sawangmake, Chenphop7,8,9 (AUTHOR), Rodprasert, Watchareewan8,9 (AUTHOR), Le, Quynh Dang8,9 (AUTHOR), Purbantoro, Steven Dwi8,9 (AUTHOR)
Publikováno v:
Scientific Reports. 9/20/2023, Vol. 13 Issue 1, p1-12. 12p.
Efficacy of the combination of monoclonal antibodies against the SARS-CoV-2 Beta and Delta variants.
Autor:
Boonkrai, Chatikorn1,2 (AUTHOR), Cotrone, Thomas S.3 (AUTHOR), Chaisuriyong, Watchadaporn4,5,6 (AUTHOR), Tantawichien, Terapong6,7 (AUTHOR), Thisyakorn, Usa6 (AUTHOR), Fernandez, Stefan3 (AUTHOR), Hunsawong, Taweewun3 (AUTHOR), Reed, Matthew3 (AUTHOR), Wongtangprasert, Tossapon2,8 (AUTHOR), Audomsun, Thittaya2 (AUTHOR), Phakham, Tanapati2 (AUTHOR), Attakitbancha, Chadaporn2 (AUTHOR), Saelao, Pijitra2 (AUTHOR), Focht, Dorota9 (AUTHOR), Kimbung, Raymond9 (AUTHOR), Welin, Martin9 (AUTHOR), Malik, Aijaz Ahmad10 (AUTHOR), Pisitkun, Trairak2 (AUTHOR) drnattachai@yahoo.com, Srisawat, Nattachai4,5,6,11,12,13 (AUTHOR) drnattachai@yahoo.com
Publikováno v:
PLoS ONE. 5/4/2023, Vol. 17 Issue 5, p1-20. 20p.
Autor:
Phakham, Tanapati1,2 (AUTHOR), Boonkrai, Chatikorn1,2 (AUTHOR), Wongtangprasert, Tossapon2,3 (AUTHOR), Audomsun, Thittaya2 (AUTHOR), Attakitbancha, Chadaporn2 (AUTHOR), Saelao, Pijitra2 (AUTHOR), Muanwien, Phijitra2 (AUTHOR), Sooksai, Sarintip4 (AUTHOR), Hirankarn, Nattiya5,6 (AUTHOR), Pisitkun, Trairak2,5 (AUTHOR) trairak.p@chula.ac.th
Publikováno v:
Scientific Reports. 10/22/2022, Vol. 12 Issue 1, p1-12. 12p.